Myocardial perfusion stress test: is it worth?
| Autor: | Marijana Tadic, Vera Artiko, Isidora Grozdic Milojevic, Bogomir Milojevic, Dragana Sobic-Saranovic |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Cardiovascular event
Coronary angiography Male Technetium Tc 99m Sestamibi medicine.medical_specialty Time Factors Myocardial Ischemia Contrast Media 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Stress test Predictive Value of Tests Internal medicine Medicine Humans Radiology Nuclear Medicine and imaging In patient 030212 general & internal medicine Cardiac imaging Dyslipidemias Tomography Emission-Computed Single-Photon business.industry Myocardial Perfusion Imaging Reproducibility of Results Prognosis SSS Cardiology Disease Progression Exercise Test Ischaemic heart disease Female Cardiology and Cardiovascular Medicine business Perfusion Echocardiography Stress |
| Zdroj: | The international journal of cardiovascular imaging. 36(4) |
| ISSN: | 1875-8312 |
| Popis: | To test the utility of the Tc99m-sestaMIBI myocardial perfusion stress test (MPS) over stress echo test (SEHO) in dyslipidemic patients with intermediate pre-test probability score. 56 dyslipidemic patients (42 males and 14 females) with a suspected/known ischaemic heart disease and intermediate pre-test probability score underwent MPS and SEHO. They were followed for 25.77 ± 6.19 months. The data about the new-onset cardiac events and possible coronary angiography (CA) were collected. MPS was positive in 80% of the patients, SEHO in 68% of the patients. Results of the SEHO and MPS showed a good correlation (p < 0.001, μ = 0.505). Both procedures had a good correlation with CA findings in the follow-up. Cardiac events occurred in 57% of the patients. The MPS result, SSS, SDS were significantly associated with the new-onset cardiac events (p < 0.05). The patients with higher SDS had more chance to get a cardiac event in the follow-up (ROC curve area = 0.719, p = 0.003). MPS sensitivity was 91%, specificity 56%; SEHO sensitivity 85% and specificity 61%. MPS may be useful in predicting a future cardiovascular event. It is sufficiently informative, objectified by quantification software, and with correspondingly reduced radiation doses it may be the method of choice in patients with intermediate pre-test probability score. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink